Related references
Note: Only part of the references are listed.Tunable Protease-Activatable Virus Nanonodes
Justin Judd et al.
ACS NANO (2014)
Real-time In Vivo Molecular Detection of Primary Tumors and Metastases with Ratiometric Activatable Cell-Penetrating Peptides
Elamprakash N. Savariar et al.
CANCER RESEARCH (2013)
Site-Specific Modification of Adeno-Associated Viruses via a Genetically Engineered Aldehyde Tag
Yarong Liu et al.
SMALL (2013)
Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem Cells
Prashanth Asuri et al.
MOLECULAR THERAPY (2012)
Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity
Justin Judd et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Glycated AAV Vectors: Chemical Redirection of Viral Tissue Tropism
Eric D. Horowitz et al.
BIOCONJUGATE CHEMISTRY (2011)
An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells
Jae-Hyung Jang et al.
MOLECULAR THERAPY (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Directed evolution of adeno-associated virus for glioma cell transduction
Casey A. Maguire et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Gary A. Rosenberg
LANCET NEUROLOGY (2009)
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Lin Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adeno-associated virus-2 and its primary cellular receptor-Cryo-EM structure of a heparin complex
Jason O'Donnell et al.
VIROLOGY (2009)
Clinical gene therapy using recombinant adeno-associated virus vectors
C. Mueller et al.
GENE THERAPY (2008)
Coating of adeno-associated virus with reactive polymers can ablate virus tropsim, enable retargeting and provide resistance to neutralising antisera
Robert C. Carlisle et al.
JOURNAL OF GENE MEDICINE (2008)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases
Christoph Springfeld et al.
CANCER RESEARCH (2006)
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris
E Zouridakis et al.
CIRCULATION (2004)
Role of proteases in the pathophysiology of cardiac disease
RB Singh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups
JE Rabinowitz et al.
JOURNAL OF VIROLOGY (2004)
Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome
CB Jones et al.
CARDIOVASCULAR RESEARCH (2003)
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding
SR Opie et al.
JOURNAL OF VIROLOGY (2003)
Generation and characterization of chimeric recombinant AAV vectors
B Hauck et al.
MOLECULAR THERAPY (2003)
Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands
S Ponnazhagan et al.
JOURNAL OF VIROLOGY (2002)
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells
K Pajusola et al.
JOURNAL OF VIROLOGY (2002)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
SA Nicklin et al.
MOLECULAR THERAPY (2001)
Share Paper
